Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-28
2010-12-14
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07851484
ABSTRACT:
Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of muscle weakness and/or cachexia, as part of a rehabilitation or conditioning exercise regimen, or in the treatment of fraility, post-polio syndrome, obesity, sarcopenia, wasting syndrome, muscle spasm, and other indications.
REFERENCES:
patent: 3507866 (1970-04-01), Jones et al.
patent: 4195088 (1980-03-01), Barzaghi et al.
patent: 4943573 (1990-07-01), Meanwell
patent: 6162804 (2000-12-01), Bilodeau et al.
patent: 6232320 (2001-05-01), Stewart et al.
patent: 6579882 (2003-06-01), Stewart et al.
patent: 6638933 (2003-10-01), Gerlach et al.
patent: 6657064 (2003-12-01), Gerlach et al.
patent: 7279580 (2007-10-01), Goodacre et al.
patent: 7348339 (2008-03-01), Bailey et al.
patent: 2003/0220365 (2003-11-01), Stewart et al.
patent: 2004/0023972 (2004-02-01), Sundermann et al.
patent: 2004/0166137 (2004-08-01), Lackey
patent: 2005/0197328 (2005-09-01), Bailey et al.
patent: 2005/0250794 (2005-11-01), Napper et al.
patent: 2006/0019952 (2006-01-01), Distefano et al.
patent: 2006/0148805 (2006-07-01), Chen et al.
patent: 2007/0197507 (2007-08-01), Morgan et al.
patent: 2007/0275984 (2007-11-01), Imogai et al.
patent: 2008/0096903 (2008-04-01), Chen et al.
patent: 2008/0146561 (2008-06-01), Muci et al.
patent: 2008/0242695 (2008-10-01), Morgan et al.
patent: 2009/0023724 (2009-01-01), Mortensen et al.
patent: 2009/0082370 (2009-03-01), Thompson et al.
patent: 2009/0247538 (2009-10-01), Berdini et al.
patent: 2010/0022564 (2010-01-01), Davies et al.
patent: 2241575 (1973-03-01), None
patent: 2 174 987 (1986-11-01), None
patent: 2 190 676 (1987-11-01), None
patent: 2 400 101 (2004-10-01), None
patent: WO 99/62908 (1999-12-01), None
patent: WO 2005/002520 (2005-01-01), None
patent: WO 2005/060711 (2005-07-01), None
patent: WO 2005/072412 (2005-08-01), None
patent: WO 2005/108374 (2005-11-01), None
patent: WO 2006/030031 (2006-03-01), None
patent: WO 2006/036883 (2006-04-01), None
patent: WO 2006/046024 (2006-05-01), None
patent: WO 2007/125321 (2007-11-01), None
patent: WO 2007/125321 (2007-11-01), None
patent: WO 2008/016648 (2008-02-01), None
patent: WO 2008//049105 (2008-04-01), None
patent: WO 2008/051493 (2008-05-01), None
patent: WO 2008/089459 (2008-07-01), None
Bianchi et al., European Journal of Medicinal Chemistry (1983), 18(6), 501-6.
Meanwell et al., Journal of Medicinal Chemistry (1991), 34(9), 2906-16.
Lindstroem et al., Heterocycles (1994), 38(3), 529-40.
Yutilov et al., Russian Journal of Organic Chemistry (2005), 41(3), 450-454.
Yutilov et al., Russian Journal of Organic Chemistry (2005), 41(4), 575-579.
International Search Report and Written Opinion mailed Jul. 1, 2008 for PCT/US2008/004075.
International Search Report and Written Opinion mailed Aug. 8, 2008 for PCT/US2007/017191.
International Search Report and Written Opinion mailed Oct. 1, 2008 for PCT/US2007/017235.
Office Action mailed Oct. 21, 2008 for U.S. Appl. No. 11/888,902, filed Aug. 1, 2007.
Jordan, Nature Reviews, Drug Discovery 2:205-213 (Mar. 2003).
Dorwald, Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH & Co., KGaA, Preface (2005).
Barliln, Aust. J. Chem., 25:2299-2306 (1982).
International Search Report and Written Opinion mailed Apr. 8, 2009 for PCT/US2009/000686.
Office Action mailed Mar. 5, 2009 for U.S. Appl. No. 11/888,902, filed Aug. 1, 2007.
Lima et al., Current Medicinal Chemistry 12(1):23-49 (2005).
Notice of Allowance for U.S. Appl. No. 11/888,902 mailed Jun. 1, 2009.
Bjoerk, Malin et al., “Synthesis of novel 2-aminoimidazo [4,5-b] pyridines, including the thieno analogue of the cooked-food mutagen IFP”,Journal of Heterocyclic Chemistry, 43(1) :101-109 (2006).
Meanwell, Nicholas A. et al., “Inhibitors of blood platelet cAMP phosphodiesterase.2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains”,Journal of Medicinal Chemistry, 35(14):2672-87 (1992).
Meanwell, Nicholas A. et al., “Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility”,Journal of Medicinal Chemistry, 35(14): 2688-96 (1992).
Supplementary European Search Report mailed Apr. 8, 2010, for PCT/US2008/004075.
Ashcraft Luke W.
Bergnes Gustave
Browne, IV William F.
Collibee Scott
Garard Marc Andrew
Andres Janet L
Cytokinetics Inc.
Rahmani Niloofar
Stevens Lauren L.
LandOfFree
Certain chemical entities, compositions, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain chemical entities, compositions, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain chemical entities, compositions, and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4208992